
	Gilead Sciences&nbsp;is an American&nbsp;biotechnology&nbsp;company that discovers, develops and commercializes&nbsp;therapeutics. For many years since the company was founded, the company concentrated primarily on&nbsp;antiviral drugs&nbsp;to treat patients infected with&nbsp;HIV,&nbsp;hepatitis B, or&nbsp;influenza. In 2006, Gilead acquired two companies that were developing drugs to treat patients with&nbsp;pulmonary&nbsp;diseases. The company has fourteen commercially available products. Headquartered and founded in&nbsp;Foster City, California, Gilead has operations in North America, Europe and Australia. As of the end of 2009, the company had approximately 4,000 full-time employees.
